Description: potassium voltage-gated channel, Shal-related subfamily, member 3
Gene: Kcnd3
Alias: Kv4.3, kcnd3, Kncd3

Edit - History


Kv4.3, encoded by the gene KCND3, is a member of the potassium voltage-gated channel subfamily D. Kv4.3 regulate repolarization of cardiac action potentials, firing frequency in neurons and dendritic excitability. [298]

Experimental data



Species NCBI gene ID Chromosome Position
Human 3752 1 219006
Mouse 56543 3 222112
Rat 65195 2 217395



Species NCBI accession Length (nt)
Human NM_004980.5 7882
Mouse NM_001039347.2 7609
Rat NM_001270962.1 6818


Protein Isoforms

Species Uniprot ID Length (aa)
Human Q9UK17 655
Mouse Q9Z0V1 655
Rat Q62897 655


Length (nt)
Length (aa)


Post-Translational Modifications


Edit - History


Visual Representation of Kv4.3 Structure
Methodology for visual representation of structure available here

Altering Residues

Changing arginine residues in the S4 domain of Kv4.3 with alanine altered activation and deactivation processes as well as closed-state inactivation and recovery - consistent with general predictions of the Kv1 channel model. [297]

The absence of the basic residue R1 in Kv4.3 can only partially account for differences in the effective voltage sensitivity of gating between Shaker (Kv1) - in which R1 is found - and Kv4.3. [298]

Kv4.3 predicted AlphaFold size

Species Area (Å2) Reference
Human 8491.13 source
Mouse 8033.89 source
Rat 6564.25 source

Methodology for AlphaFold size prediction and disclaimer are available here

Edit - History


Single Channel Conductance

4ps [467]

Kv4.3 Kinetics vary with Temperature

Our data demonstrated that the biophysical characteristics of Kv4.3/KChIP2 channels are strongly dependent on temperature. The time courses of activation, inactivation and recovery from inactivation were accelerated with increased temperature. KCNE1 did not significantly affect the current kinetics of Kv4.3/KChIP2 channels at 23 °C or 37 °C. In contrast to KCNE1, KCNE2 significantly slowed the time courses of activation, inactivation and recovery from inactivation of Kv4.3/KChIP2 channels at physiological temperature [1556]

KV4.3 Inactivation


The steady-state inactivation of Kv4.3 was examined using a standard two-pulse protocol. Representative Kv4.3 currents are shown in Fig. 6a. The steady-state inactivation curve was also shifted in the hyperpolarizing direction after treatment with mosapride. The half-inactivation potential (V1/2) and the slope factor (k) of the steady-state inactivation curve changed from −58.1±1.0 and 5.2±0.1 mV under control conditions to −62.9±1.8 and 5.3±0.2 mV (n=10, P<0.05), respectively.

Kv4.3 Kinetics


Under control conditions, the time course of Kv4.3 inactiva- tion at +40 mV can be described as a biexponential process with a fast time constant of 21.1±2.4 ms and a slow time constant of 143.4 ± 19.7 ms (n = 8). The fast and slow components of inactivation represented 83.9 ± 2.5 and 16.1 ± 2.5 % (n = 8) of total inactivation, respectively.

Edit - History


Markov Model Kv4.3


Our model for activation of the Kv4.3 channel contains only five closed states, with four voltage-dependent and one voltage-independent transitions. We investigated the time course of activation development and found that the best fit is achieved with the exponential function C[1 − exp(−t/τact)]n, where n = 4 or n = 5, but the differences between the fits were minor. Therefore, we used a model with four voltage-dependent steps to analyse Kv4.3 channel activation [449]

Markov Model (transition rates voltage AND TEMPERATURE dependent)

Kv4.3 markov

This model consists of four closed states (C0–C3), four closed-inactivated states (CI0–CI3), one open state (O) and one open-inactivated state (OI). Expanding the model, the transition rates αa and βa are designed here as voltage- as well as temperature-dependent, transition rates αi and βi are temperature-dependent only. Scaling factors (f1–f4; b1–b4) permit coupling of inactivation to activation as reported [1556]

Hodgkin and Huxley Model of Activation


A classical Hodgkin–Huxley model of activation should show a smooth bell-shaped voltage-dependent transition between τact and τdeact. As shown in the figure there is a steep transition between the τact and the τdeact over a narrow voltage range between −60 and −40 mV at 2 mm[K+]o, which was more marked at high [K+]o [449]

Hodgkin and Huxley Model of Open State Inactivation


Activation kinetics obtained from simulated data that did and did not contain a fast open-inactivated state using a Hodgkin–Huxley-like activation equation C[1 − exp(−t/τact)]4 [449]

Edit - History

Expression and Distribution

Expression in the Brain

While in rat brain Kv4.2 and Kv4.3 are prevalent, all Kv4 proteins are clearly present in human brain. Neurons in the substantia nigra pars compact, the restrosplenial cortex, the superior colliculus, the raphe, and the amygdala express mainly Kv4.3. In the olfactory bulb Kv4.3 is highly expressed in periglomerular cells and in CA2-CA3 pyramidal cells and in granule cells of the dentate gyrus [466]

Expressed in Several Tissues

Finally, the mRNAs for Kv4.1 and Kv4.3 have been found in a variety of other tissue including skeletal muscle, spleen, thymus, bone marrow, liver, pancreas, prostrate, and kidney tissue [466]

Kv4.3 is abundant in rat adult brain and heart tissues.[328]

Only Kv4.3L (long version), but not Kv4.1, Kv4.2, Kv1.4, or Kv3.4, is expressed in single dopaminergic substantia nigra neurons [467]

Co-localization with KChIP1

KChIP1 co-localizes with Kv4.3 in hippocampal interneurons, cerebellar granule cells and synaptic glomeruli within the cerebellar granule cell layer. Co-immunoprecipitation analyses confirmed that the KChIPs are tightly associated with Kv4 alpha-subunits in brain potassium channel complexes [1195]

Edit - History

CNS Sub-cellular Distribution

Distribution of Kv4.3 and 4.2 in Mouse Neuron

In all layers, clusters of Kv4.2 and Kv4.3 immunoreactivity are evident in the membranes of the somata, dendrites, and spines of pyramidal cells and GABAergic interneurons. Electron microscopic analyses revealed that Kv4.2 and Kv4.3 clusters in pyramidal cells and interneurons are excluded from putative excitatory synapses, whereas postsynaptic membranes at GABAergic synapses often contain Kv4.2 and Kv4.3. The presence of Kv4 channels at GABAergic synapses would be expected to weaken inhibition during dendritic depolarization by backpropagating action potentials. The extrasynaptic localization of Kv4 channels near excitatory synapses, in contrast, should stabilize synaptic excitation during dendritic depolarization. Thus, the synapse-specific distribution of Kv4 channels functions to optimize dendritic excitation and the association between presynaptic and postsynaptic activity [319]

Edit - History


Repolarizing action potential

Channels of the Kv4 (Shal-type) family generate rapidly activating and inactivating potassium currents in response to membrane depolarization, significantly modulating action potential repolarization and frequency-dependent electrical signaling. The current associated with Kv4 channels (IA) has thus been hypothesized to play important functional roles in diverse excitable cell types, including neuronal somatodendritic interactions [466] [467], long-term potentiation [468], pain plasticity [470], and excitation-contraction coupling in smooth and cardiac muscle [469].

Regulation of Electrophysiological Process

Kv4.3 channels have been implicated in the modulation of a wide range of electrophysiological processes in these cells: maintenance of membrane potential, regulation of the duration of action potential and the interspike interval, and attenuation of back-propagating action potentials [466]

Therapeutic targets of disease

Since alteration of Kv4.3 channel activities has resulted in several pathological conditions, these channels are considered to be a potential therapeutic target for diseases such as stroke, Alzheimer’s disease, arrhythmias, and cardiac hypertrophy [1555]

GI Smooth Muscle

Several lines of evidence have sug- gested that Kv4.3 currents may be one of the major molecular correlates of A-type Kv currents in many GI smooth muscles [467]

Kv4 regulates Spatial Memory

Significant differences in Kv4.2 and Kv4.3 mRNA levels were observed between conditioned and pseudoconditioned rats. Spatial learning performance was positively correlated with the levels of Kv4.2 and Kv4.3 mRNAs in several of these brain structures. Altogether our findings suggest that Kv4 channels could increase the signal-to-noise ratio during information acquisition, thereby allowing a better encoding of the memory trace [1557]

Atrial Fibrillation

Patients with paroxysmal or persistent AF have decreased Kv4.3 protein and mRNA levels, as well as reduced Ito current densities [1751]

Edit - History



Calcium-binding proteins dubbed KChIPs favour surface expression and modulate inactivation gating of neuronal and cardiac A-type Kv4 channels. An allosteric kinetic model explaining kinetic changes that KChIP1 has on Kv4.1 and Kv4.3 channels can be found at [25].

At the cellular level, it has been shown that KChIP1 colocalizes with Kv4.3 in hippocampal interneurons and cerebellar granule cells. Based on the differential ability of KChIP2 and frequenin/NCS-1 to bind Kv4.3 proteins, coimmunoprecipitation analysis using KChIP2-frequenin chimeras shows that two EF-hand linkers (those between first and second EF hands and between third and fourth EF hands), and the C-terminal portion following the fourth EF hand are the determinants of KChIP association with Kv4.3 proteins [467]

Furthermore, mutations in the inner vestibule of Kv4.3 (V(399,401)I) significantly increased the sustained, noninactivating component and eliminated the ability of KChIP2b to accelerate slow phase of inactivation [467]


The effects of β-subunits specifically on Kv4.x channel function is still under investigation. While Kvβ1.2 does not affect Kv4.2 channel gating kinetics, it does confer sensitivity to redox modulation and hypoxia. Kv4.3 interacts with all three known β-subunits (β1, β2, and β3). Kvβ1 and 2 cause an increase in Kv4.3 channel current density, with no effect on channel gating, while β3 shifts steady-state inactivation and slows recovery from inactivation [466]

Kv4.3/KChIP2 channels without transmembrane β-subunits showed the strongest temperature sensitivity with considerably increased rates of activation and inactivation at 37 °C. KCNE2 significantly slowed the current kinetics at 37 °C compared to Kv4.3/KChIP2 channels, whereas KCNE1 did not influence the channel properties at both temperatures.

Rubidium Ions

When Rb+ is the current carrying ion in all Kv4 channels, both the development of deactivation and inactivation are slowed and the peak currents are increased.[27]

4-aminopyridine (4-AP)

4-AP blocks native Kv4 A-type K+ channels from cardiac tissue and cloned Kv4 K+ channels.[24] [26]. Kv4.2 also expresses suppression with a half-inhibition concentration at the low millimolar levels [467]


Kv4 currents and ISA have very similar pharmacological profiles. Both Kv4 current and ISA exhibit insensitivity to external TEA up to 20 mM [467]


The association of DPPX with Kv4 channels increases current expression between 3 and 25 times due to increased trafficking, as determined by current recordings and immunohistochemistry. For Kv4.2 and Kv4.3, DPPX-S shifts the voltage dependence of activation and inactivation to more hyperpolarized potentials and significantly accelerates the time courses of activation, inactivation, and recovery from inactivation [467]


Although kinetic effects of CaMKII were not seen in studies on Kv4.2, exposure of rat Kv4.3 stably expressed in HEK cells to KN-93 or synthetic CaMKII inhibitor accelerates inactivation and slows recovery, whereas presence of autophosphorylated CaMKII slows inactivation and accelerates recovery. Thus, CaMKII phosphorylation may be more significant for regulating the levels of functional channels rather than the gating properties of the channels already present on the cell surface [467]


PKA activation does not modulate the gating of Kv4.2 when it is expressed alone. Likewise, application of phorbol 12-myristate 13-acetate (PMA) to oocytes expressing Kv4.2 or Kv4.3 currents produces a marked decrease in their peak amplitude in a dose dependent manner; however, like PKA there were no significant shifts in voltage dependence of activation. In studies of the expression Kv4.3 splice variants in mammalian L-cells, it was found that the long splice variant of Kv4.3 was selectively downregulated by PKC activation, due to a consensus PKC site contained in the alternative spliced exon ( [467]


Leptin treatment induced an up-regulation of Kv4.2, Kv4.3 and KChIP2 subunits mRNA expression. Protein expression levels of Kv4.2, Kv4.3 and KChIP2 subunits were also increased by leptin. The electrophysiological study showed that leptin increases the fast transient outward potassium current amplitudes and densities shortening action potential duration [1553]

Mosapride and Cisapride

Mosapride and cisapride are gastroprokinetic agents with 5-hydroxytryptamine4 receptor agonist activity and have been widely used in the treatment of a variety of gastrointestinal disorders. Mosapride and cisapride inhibited Kv4.3 in a concentration-dependent manner with IC50 values of 15.2 and 9.8 μM, respectively. Mosapride accelerated the rate of inactivation and activation of Kv4.3 in a concentration-dependent manner and thereby decreased the time to peak [1554]


Ajmaline is a class Ia anti-arrhythmic compound that is widely used for the diagnosis of Brugada syndrome and the acute treatment of atrial or ventricular tachycardia. When expressed in a mammalian cell line, ajmaline inhibits Kv4.3 with an IC50 of 2.66 μM [1558]


Since the downregulation of Kv4.3 K(+) channels and the upregulation of BMP4 (bone morphogentic protein 4) simultaneously occur in pathological cardiac hypertrophy, we hypothesize that the up-regulated BMP4 would contribute to the downregulation of Kv4.3 K(+) channels in cardiac hypertrophy. We found that BMP4 treatment reduced Kv4.3 but not Kv4.2 and Kv1.4 K(+) channel protein expression [1559]




Shahidullah M et al. The link between ion permeation and inactivation gating of Kv4 potassium channels.
Biophys. J., 2003 Feb , 84 (928-41).



Wang S et al. Activation properties of Kv4.3 channels: time, voltage and [K+]o dependence.
J. Physiol. (Lond.), 2004 Jun 15 , 557 (705-17).


Birnbaum SG et al. Structure and function of Kv4-family transient potassium channels.
Physiol. Rev., 2004 Jul , 84 (803-33).


Jerng HH et al. Molecular physiology and modulation of somatodendritic A-type potassium channels.
Mol. Cell. Neurosci., 2004 Dec , 27 (343-69).


Thompson SM IA in play.
Neuron, 2007 Jun 21 , 54 (850-2).


Hu HJ et al. The kv4.2 potassium channel subunit is required for pain plasticity.
Neuron, 2006 Apr 6 , 50 (89-100).

Sung KW et al. Effect of mosapride on Kv4.3 potassium channels expressed in CHO cells.
Naunyn Schmiedebergs Arch. Pharmacol., 2013 Oct , 386 (905-16).

Wulff H et al. Voltage-gated potassium channels as therapeutic targets.
Nat Rev Drug Discov, 2009 Dec , 8 (982-1001).

Radicke S et al. Accessory subunits alter the temperature sensitivity of Kv4.3 channel complexes.
J. Mol. Cell. Cardiol., 2013 Jan 3 , ().

Fischer F et al. Inhibition of cardiac Kv1.5 and Kv4.3 potassium channels by the class Ia anti-arrhythmic ajmaline: mode of action.
Naunyn Schmiedebergs Arch. Pharmacol., 2013 Nov , 386 (991-9).

Grammer JB et al. Molecular remodeling of Kv4.3 potassium channels in human atrial fibrillation.
J. Cardiovasc. Electrophysiol., 2000 Jun , 11 (626-33).

Edit - History


Contributors: Rajnish Ranjan, Michael Schartner, Nitin Khanna

To cite this page: [Contributors] Channelpedia , accessed on 2024 Apr 15